Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01740115 · ClinicalTrials.gov registry record
Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 250
- Enrollment target
NCT01740115: Completed study, sponsored by Boston Medical Center.
NCT01740115 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01740115 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The purpose of this study is to expand and continue a cohort of HIV-infected adults to establish the longitudinal Boston ARCH Cohort of 250 HIV-infected men and women with current substance dependence or ever injection drug use that have a spectrum of alcohol use; and to determine the effect of alcohol consumption on changes in bone health prospectively in the Cohort.
Primary Outcome
Bone mineral density will be measured using Hologic QDR 4500W enhanced-array, whole-body, dual-energy radiographic absorptiometry scanner and software, version 13.4.2 (Bone Densitometer)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2012-11 |
| Est. Completion | 2016-08 |
What the finished NCT01740115 record still lists
NCT01740115 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01740115 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01740115 about?
NCT01740115 is a clinical study titled "Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort". The purpose of this study is to expand and continue a cohort of HIV-infected adults to establish the longitudinal Boston ARCH Cohort of 250 HIV-infected men and women with current substance dependence or ever injection drug use that have a spectrum of alcohol use; and to determine the effect of alco...
What is the current status of trial NCT01740115?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2012-11. Estimated completion is 2016-08.
Who is sponsoring clinical trial NCT01740115?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia